East Of England NHS Collaborative Hub c/o West Suffolk Hospital NHS Foundation Trust
Victoria House, Capital Park
Fulbourn
CB21 5XB
UK
Telephone: +44 7766763859
E-mail: pharmacy@eoecph.nhs.uk
NUTS: UK
Internet address(es)
Main address: www.eoecph.nhs.uk
Address of the buyer profile: https://eoecph.bravosolution.co.uk
The procurement documents are available for unrestricted and full direct access, free of charge at:
II.1.1) Title
Supply and Delivery of Radiopharmaceuticals
II.1.2) Main CPV code
33151000
II.1.3) Type of contract
Supplies
II.1.4) Short description
The East of England NHS Collaborative Procurement Hub (EoECPH) wishes to establish a multi-provider Framework Agreement for the Supply and delivery of radiopharmaceuticals, covering; radiopharmaceuticals, isotopes, generators and ready-made radiopharmaceuticals.
II.1.5) Estimated total value
Value excluding VAT:
40 000 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
Yes
Tenders may be submitted for all lots
Lot No: 1
II.2.1) Title
Generators
II.2.2) Additional CPV code(s)
33151000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The supply and delivery of generators, in particular technetium, gallium and krypton. The Framework Agreement will include and be for the benefit of publicly funded (both wholly and partially funded) entities in the United Kingdom, including Northern Ireland, Scotland, Wales and England. This will include, but is not limited to: acute, ambulance, mental health, clinical commissioning groups, health and care trusts, area teams, local authorities and special health authorities, HSC in Northern Ireland, NHS Scotland and NHS Wales, including any successor or emerging organisations, which will include but is not limited to the emerging landscape of combined health and social care commissioners and providers. Please follow the links below to identify specific organisations:
— NHS trusts: http://www.nhs.uk/ServiceDirectories/Pages/AcuteTrustListing.aspx
— clinical commissioning groups: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx
— area teams: http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx
— local authorities: http://local.direct.gov.uk/LDGRedirect/index.jsp?requestType=locator&LGSL=209&LGIL=8
— special health authorities: http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx
— HSC in Northern Ireland: http://online.hscni.net/other-hsc-organisations
— NHS Scotland: http://www.scot.nhs.uk/organisations/
— NHS Wales: http://www.wales.nhs.uk/ourservices/directory
A list of anticipated participating organisations can be found in the ITT.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
8 000 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 48
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
Yes
Description of options:
This Framework Agreement is for 12 months with the option to extend incrementally up to 48 months.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Agents (Kits), Iodine Therapy Capsules, Isotopes and Associated Items
II.2.2) Additional CPV code(s)
33151000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The supply and delivery of agents (kits), iodine therapy capsules, isotopes and associated items. The Framework Agreement will include and be for the benefit of publicly funded (both wholly and partially funded) entities in the United Kingdom, including Northern Ireland, Scotland, Wales and England. This will include, but is not limited to: acute, ambulance, mental health, clinical commissioning groups, health and care trusts, area teams, local authorities and special health authorities, HSC in Northern Ireland, NHS Scotland and NHS Wales, including any successor or emerging organisations, which will include but is not limited to the emerging landscape of combined health and social care commissioners and providers. Please follow the links below to identify specific organisations:
— NHS trusts: http://www.nhs.uk/ServiceDirectories/Pages/AcuteTrustListing.aspx
— clinical commissioning groups: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx
— area teams: http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx
— local authorities: http://local.direct.gov.uk/LDGRedirect/index.jsp?requestType=locator&LGSL=209&LGIL=8
— special health authorities: http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx
— HSC in Northern Ireland: http://online.hscni.net/other-hsc-organisations
— NHS Scotland: http://www.scot.nhs.uk/organisations/
— NHS Wales: http://www.wales.nhs.uk/ourservices/directory
A list of anticipated participating organisations can be found in the ITT.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
20 000 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 48
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
Yes
Description of options:
This Framework Agreement is for 12 months with the option to extend incrementally up to 48 months.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
Ready made Radiopharmaceutcials
II.2.2) Additional CPV code(s)
33151000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The supply and delivery of ready made radiopharmaceuticals including but not limited to kits, kits dispensed at unit dose and labelled patient doses. The Framework Agreement will include and be for the benefit of publicly funded (both wholly and partially funded) entities in the United Kingdom, including Northern Ireland, Scotland, Wales and England. This will include, but is not limited to: acute, ambulance, mental health, clinical commissioning groups, health and care trusts, area teams, local authorities and special health authorities, HSC in Northern Ireland, NHS Scotland and NHS Wales, including any successor or emerging organisations, which will include but is not limited to the emerging landscape of combined health and social care commissioners and providers. Please follow the links below to identify specific organisations:
— NHS trusts: http://www.nhs.uk/ServiceDirectories/Pages/AcuteTrustListing.aspx
— clinical commissioning groups: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx
— area teams: http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx
— local authorities: http://local.direct.gov.uk/LDGRedirect/index.jsp?requestType=locator&LGSL=209&LGIL=8
— special health authorities: http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx
— HSC in Northern Ireland: http://online.hscni.net/other-hsc-organisations
— NHS Scotland: http://www.scot.nhs.uk/organisations/
— NHS Wales: http://www.wales.nhs.uk/ourservices/directory
A list of anticipated participating organisations can be found in the ITT.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6) Estimated value
Value excluding VAT:
12 000 000.00
GBP
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 48
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
Yes
Description of options:
This Framework Agreement is for 12 months with the option to extend incrementally up to 48 months.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No